Thomas Skot Jensen
Background and experience
Thomas leads ZS’s European biomedical research team, uniting biology, data science and AI to help pharma and biotech accelerate discovery and improve R&D outcomes.
He established a science-led team that uses a combination of biological knowledge, deep data experience and AI capabilities. This helps clients to achieve breakthrough discoveries, increase R&D outcomes and accelerate drug discovery. Thomas works with pharma and biotech companies to convert omics data into novel insights at molecular, systemic and patient level. He also helps clients establish scalable analytic capabilities to meet current and future demands for data-driven research and development.
Thomas’ expertise includes predictive science, research strategy and cross-discipline collaborations, which are essential to leverage client capabilities and harness the exponential biomedical data growth. He has more than 20 years of experience delivering novel and tailored approaches to target discovery, precision medicine, drug repurposing and patient stratification. In addition, Thomas has experience working across various therapeutic areas using structured, unstructured and emerging data types.
Thomas has led and grown teams and established best practices for bioinformatics and data analytics, both in academia and industry. Thomas co-founded and served as CEO of Intomics, a deep data and AI company pioneering the use of multiomics approaches and network biology in drug discovery. Intomics was acquired by ZS in 2022 to assist clients in pursuing breakthrough science and innovative medicines to improve patients’ lives.
Education
M.S., chemical engineering, Technical University of Denmark
Ph.D., bioinformatics and systems biology, Technical University of Denmark